Elsevier

Annals of Oncology

Volume 32, Supplement 5, September 2021, Pages S1015-S1016
Annals of Oncology

1325P Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)

https://doi.org/10.1016/j.annonc.2021.08.1926Get rights and content
Under an Elsevier user license
open archive

Cited by (0)